A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge

References

• O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902; PMID:19748398; http://dx.doi.org/10.1016/S0140-6736(09)61204-6
   PubMed Web of Science ®Google Scholar
• Moffitt KL, Malley R. Next generation pneumococcal vaccines. Curr Opin Immunol 2011; 23:407-13; PMID:21514128; http://dx.doi.org/10.1016/j.coi.2011.04.002
   PubMed Web of Science ®Google Scholar
• Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010; 7:e1000348; PMID:20957191
   PubMed Web of Science ®Google Scholar
• Mehr S, Wood N. Streptococcus pneumoniae–a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev 2012; 13:258-64; PMID:23069126; http://dx.doi.org/10.1016/j.prrv.2011.12.001
   PubMed Web of Science ®Google Scholar
• Pittet LF, Posfay-Barbe KM. Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect 2012; 18 (Suppl 5):25-36; PMID:22862432; http://dx.doi.org/10.1111/j.1469-0691.2012.03938.x
   PubMed Web of Science ®Google Scholar
• Kallio A, Sepponen K, Hermand P, Denoel P, Godfroid F, Melin M. Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells. Infect Immun 2014; 82:1683-91; PMID:24491577; http://dx.doi.org/10.1128/IAI.00699-13
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 2012; 30:2900-7; PMID:22349524; http://dx.doi.org/10.1016/j.vaccine.2012.02.023
   PubMed Web of Science ®Google Scholar
• Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 2001; 69:949-58; PMID:11159990; http://dx.doi.org/10.1128/IAI.69.2.949-958.2001
   PubMed Web of Science ®Google Scholar
• Turner P, Turner C, Green N, Ashton L, Lwe E, Jankhot A, Day NP, White NJ, Nosten F, Goldblatt D. Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study. Clin Microbiol Infect 2013; 19:E551-8; PMID:24255996; http://dx.doi.org/10.1111/1469-0691.12286
   PubMed Web of Science ®Google Scholar
• Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Kayhty H. Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine 2009; 27:4615-21; PMID:19524618; http://dx.doi.org/10.1016/j.vaccine.2009.05.071
   PubMed Web of Science ®Google Scholar
• Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, Montagnani F, Oggioni M, Pozzi G, Felici F. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol Lett 2006; 262:14-21; PMID:16907734; http://dx.doi.org/10.1111/j.1574-6968.2006.00360.x
   PubMed Web of Science ®Google Scholar
• Rioux S, Neyt C, Di Paolo E, Turpin L, Charland N, Labbe S, Mortier MC, Mitchell TJ, Feron C, Martin D, et al. Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology 2011; 157:336-48; PMID:20966093; http://dx.doi.org/10.1099/mic.0.042184-0
   PubMed Web of Science ®Google Scholar
• Yun KW, Lee H, Choi EH, Lee HJ. Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children. PloS One 2015; 10:e0134055; PMID:26252211; http://dx.doi.org/10.1371/journal.pone.0134055
   PubMedGoogle Scholar
• Kaur R, Surendran N, Ochs M, Pichichero ME. Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun 2014; 82:5069-75; PMID:25245804; http://dx.doi.org/10.1128/IAI.02124-14
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun 2013; 81:3781-92; PMID:23897609; http://dx.doi.org/10.1128/IAI.00313-13
   PubMed Web of Science ®Google Scholar
• Godfroid F, Hermand P, Verlant V, Denoel P, Poolman JT. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun 2011; 79:238-45; PMID:20956575; http://dx.doi.org/10.1128/IAI.00378-10
   PubMed Web of Science ®Google Scholar
• Verhoeven D, Perry S, Pichichero ME. Contributions to Protection from Streptococcus pneumoniae Infection Using Monovalent Recombinant Protein Vaccine Candidates PcpA, PhtD and PlyD1 in an Infant Murine Model During Challenge. Clin Vaccine Immunol 2014; 21:1037-45; PMID:24850621
   PubMed Web of Science ®Google Scholar
• Denoel P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine 2011; 29:5495-501; PMID:21624422; http://dx.doi.org/10.1016/j.vaccine.2011.05.051
   PubMed Web of Science ®Google Scholar
• Seiberling M, Bologa M, Brookes R, Ochs M, Go K, Neveu D, Kamtchoua T, Lashley P, Yuan T, Gurunathan S. Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults. Vaccine 2012; 30:7455-60; PMID:23131206; http://dx.doi.org/10.1016/j.vaccine.2012.10.080
   PubMed Web of Science ®Google Scholar
• Brookes RH, Ming M, Williams K, Hopfer R, Gurunathan S, Gallichan S, Tang M, Ochs MM. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies. Hum Vaccines Immunother 2015; 11:1836-9; PMID:25912273; http://dx.doi.org/10.1080/21645515.2015.1039210
   PubMed Web of Science ®Google Scholar
• Selva L, Ciruela P, Blanchette K, del Amo E, Pallares R, Orihuela CJ, Munoz-Almagro C. Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae. PloS One 2012; 7:e41587; PMID:NOT_FOUND.
   PubMed Web of Science ®Google Scholar
• Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun 2008; 76:2767-76; PMID:18391008; http://dx.doi.org/10.1128/IAI.01126-07
   PubMed Web of Science ®Google Scholar
• Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC. Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. J Bacteriol 2010; 192:4489-97; PMID:20601473; http://dx.doi.org/10.1128/JB.00064-10
   PubMed Web of Science ®Google Scholar
• Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, Bixler G, Hou V, Pehlic V, Yuan T, Gurunathan S. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine 2012; 30:7461-8; PMID:23123106; http://dx.doi.org/10.1016/j.vaccine.2012.10.076
   PubMed Web of Science ®Google Scholar
• Verhoeven D, Xu Q, Pichichero ME. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model. Vaccine 2014; 32:3205-10; PMID:24731814; http://dx.doi.org/10.1016/j.vaccine.2014.04.004
   PubMed Web of Science ®Google Scholar
• Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 2000; 182:1694-701; PMID:11069242; http://dx.doi.org/10.1086/317602
   PubMed Web of Science ®Google Scholar
• Tian H, Weber S, Thorkildson P, Kozel TR, Pirofski LA. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect Immun 2009; 77:1502-13; PMID:19168739; http://dx.doi.org/10.1128/IAI.01075-08
   PubMed Web of Science ®Google Scholar
• Posfay-Barbe KM, Galetto-Lacour A, Grillet S, Ochs MM, Brookes RH, Kraehenbuhl JD, Cevey-Macherel M, Gehri M, Gervaix A, Siegrist CA. Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A. Clin Microbiol Infect 2011; 17:1232-8; PMID:21040158; http://dx.doi.org/10.1111/j.1469-0691.2010.03389.x
   PubMed Web of Science ®Google Scholar